PSMB10
MOLECULAR TARGETproteasome 20S subunit beta 10
PSMB10 (proteasome 20S subunit beta 10) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PSMB10
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | carfilzomib | 3.69 | 39 |
| 2 | Bortezomib | 2.89 | 17 |
| 3 | delanzomib | 2.08 | 7 |
| 4 | Reserpine | 1.61 | 4 |
About PSMB10 as a Drug Target
PSMB10 (proteasome 20S subunit beta 10) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented PSMB10 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PSMB10 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.